Ubiquitin Chains: Degradation And Beyond by Arnab DeUbiquitin Chains: Degradation And Beyond by Arnab De

Ubiquitin Chains: Degradation And Beyond

byArnab De

Hardcover | March 26, 2015

Pricing and Purchase Info

$160.36 online 
$193.50 list price save 17%
Earn 802 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This thesis examines the evidence for regulatory ubiquitination by focusing on A20. It provides an insightful and in-depth evaluation of the current literature by critically examining the evidence of K63-linked regulatory ubiquitination in regulating cell-signalling. It is also the first thesis to directly test the role of regulatory ubiquitination in NF-kB signalingin vivo. The case for regulatory ubiquitination has been to a large extent predicated upon the presumed deubiquitinase activity of A20, long considered a key regulator of inflammatory responses as mice lacking A20 die from multi-organ inflammation and cachexia. The theses reports the creation and characterization of a knock-in mouse that expresses a mutated form of A20 which selectively lacks the deubiquitinase activity. The knock-in mice surprisingly display completely normal NF-κB activation with no accompanying inflammatory phenotype. Given that the presumed role of A20 as a deubiquitinase has been used to support the importance of regulatory K63-linked ubiquitination in NF-kB signaling, this study will help focus future research efforts into alternative target pathways that do not depend on K63 ubiquitination. In fact, the work suggests that it might be important to revisit the role of K63-linked polyubiquitination in cell-signalling.Ubiquitin Chains: Degradation and Beyondis essential reading for anyone conducting research in cell-signalling and immunology.

Dr. Arnab De received his PhD from the Department of Microbiology & Immunology at Columbia University. During his PhD, he developed transgenic mice to study the mechanism of action of a critical tumor-suppressor called A20. He is also well known for having developed peptide-based prodrugs as therapeutics for diabetes. His work has been reported by the media, and has resulted in multiple patents and publications in peer reviewed journals. He presented his findings at the American Peptide Symposium and was awarded the Young Investigator's Award. He is the author of the book entitledApplication of Peptide-Based Prodrug Chemistry in Drug Development, with a foreword written by Professor Jean Martinez (Former President, European Peptide Society) and published in the seriesSpringerBriefs in Pharmaceutical Science & Drug Development.His research interests lie at the intersection of chemistry and medicine. Besides biomedical research, he is also generally interested in public health policy and general scientific outreach.
Dr. Arnab De received his PhD from the Department of Microbiology & Immunology at Columbia University. During his PhD, he developed transgenic mice to study the mechanism of action of a critical tumor-suppressor called A20. He is also well known for having developed peptide-based prodrugs as therapeutics for diabetes. His work has been...
Loading
Title:Ubiquitin Chains: Degradation And BeyondFormat:HardcoverDimensions:103 pagesPublished:March 26, 2015Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3319149644

ISBN - 13:9783319149646

Look for similar items by category:

Reviews

Table of Contents

.- 1 Immune homeostasis: Activation and Downregulation of NF-κB

.- 2 Regulation of NF-κB signaling by regulatory ubiquitination: specific pathways and A20

.- 3 The deubiquitinase activity of A20 is dispensable for its role in NF-κB signaling

.- 4 Perspectives on regulatory ubiquitination.